The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
This guide helps counselors improve their skills in leading group therapy sessions for substance use treatment. The guide discusses types of group therapy, confidentiality, client placement, group development, stages of treatment, how-to tips, training, and supervision.
This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management. Access the literature review.
This manual is designed as a seven-module training guide for group therapy in substance use disorder treatment. The modules assist counselors and other clinical staff in understanding and implementing evidence-based practices as described in TIP 41. Access training modules with trainers’ notes, talking points, and slides.
This manual introduces counselors and therapists to brief intervention and therapy for mental illness, substance use disorders, or both. It presents practical methods and case scenarios for implementing shorter forms of treatment for a range of populations and issues.
Millions of Americans have a substance use disorder. Find a treatment facility near you.
Free and confidential support for people in distress, 24/7.
Find treatment facilities confidentially and anonymously, 24/7.
Treatment referral and information, 24/7.